Skip to main content
Fig. 2 | BMC Veterinary Research

Fig. 2

From: Effect of intralesional platelet-rich plasma (PRP) treatment on clinical and ultrasonographic parameters in equine naturally occurring superficial digital flexor tendinopathies – a randomized prospective controlled clinical trial

Fig. 2

B-mode ultrasonographic measurements. a Total cross sectional area of PRP- and saline treated SDFTs over time (global test: PRPG p = 0.079, CG p = 0.999). b Total echo scores of PRP- and saline treated SDFT lesions over time (global test: PRPG and CG p < 0.001). c Fiber alignment scores of PRP- and saline treated SDFT lesions over time (global test: PRPG and CG p < 0.001). Mean ± SE; Values labelled with asterisk (*) differ significantly (p < 0.05) between groups. Different letters (PRP normal and control italic) indicate significant differences (p < 0.05) within groups; PRPG = PRP-group: n = 10 limbs, SDFTs treated intralesionally with PRP; CG = control group: n = 10 limbs, SDFTs treated intralesionally with saline; black arrow = day 0: diagnosis, intralesional injection of PRP/saline; PRP = platelet-rich plasma; FAS = fiber alignment score; SDFT = superficial digital flexor tendon; TCSA = total cross sectional area; TES = total echo score; w = weeks

Back to article page

BMC Veterinary Research

ISSN: 1746-6148

Contact us